[The efficacy of cytoplasmatic therapy in elderly patients].
It has been studied whether cytoplasmatic therapy with macromolecular substances can favourably influence symptoms of the progressive aging process in old patients. For this purpose a randomized double-blind study was carried out in a geriatric clinic. A marked and statistically significant improvement was observed in the patients after four weeks real treatment as compared with the placebo group, using as criteria the ECG, the frequency of cerebral symptoms and the result of psychological tests. Concomitant chemical and haematological laboratory controls did not indicate a difference between the two treatment groups.
D000368:Aged; D000375:Aging; D001794:Blood Pressure; D064987:Cell- and Tissue-Based Therapy; D002986:Clinical Trials as Topic; D003593:Cytoplasm; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007361:Intelligence Tests; D046911:Macromolecular Substances; D008297:Male; D008875:Middle Aged; D009928:Organ Specificity; D010919:Placebos; D011581:Psychological Tests; D011897:Random Allocation; D013045:Species Specificity
D046911:Macromolecular Substances; D010919:Placebos
Zur Wirkung der zytoplasmatischen Therapie beim alten Patienten.